Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | PKM | P14618 | 2/20 | 0.41 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | TTR | P02766 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA5A | P35218 | 1/20 | 0.39 |
| ▸ | GLA | P06280 | 3/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | MIF | P14174 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30707980 | 1.00 | MAPT (0.41) | MAPTMEN1KMT2AALDH1A1PKM | |
| SCHEMBL29937598 | 0.90 | AKR1B1 (0.49) | MAPTMEN1KMT2AALDH1A1PKM | |
| SCHEMBL448275 | 0.83 | MIF (0.47) | MAPTALDH1A1SMN1; SMN2KDM4ELMNA | |
| SCHEMBL29582798 | 0.83 | MIF (0.47) | MAPTALDH1A1SMN1; SMN2KDM4ELMNA | |
| SCHEMBL449192 | 0.76 | MAOB (0.46) | MIF | |
| SCHEMBL29582422 | 0.76 | MAOB (0.46) | MIF | |
| SCHEMBL30821349 | 0.75 | MAPT (0.49) | MAPTMEN1KMT2AALDH1A1PKM | |
| SCHEMBL7389121 | 0.75 | MAPT (0.49) | MAPTMEN1KMT2AALDH1A1PKM | |
| SCHEMBL15173274 | 0.72 | SRD5A1 (0.45) | — | |
| SCHEMBL29953520 | 0.71 | MAOA (0.47) | MAPTALDH1A1MAPK14SMN1; SMN2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12522554-B2 | Method for preparing intermediate for synthesis of sphingosine-1-phosphate receptor agonist | LG CHEM, LTD. (KR) | 2026-01-13 | — | — | US | disclosed |
| US-20240217935-A1 | METHOD FOR PREPARING INTERMEDIATE FOR SYNTHESIS OF SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST | LG CHEM, LTD. (KR) | 2024-07-04 | — | — | US | disclosed |
| US-20240217935-A1 | METHOD FOR PREPARING INTERMEDIATE FOR SYNTHESIS OF SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST | LG CHEM, LTD. (KR) | 2024-07-04 | — | — | US | disclosed |
| EP-4306513-A1 | METHOD FOR PREPARING INTERMEDIATE FOR SYNTHESIS OF SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST | Lg Chem, Ltd. (KR) | 2024-01-17 | — | — | EP | disclosed |
| US-20240002322-A1 | METHOD FOR PREPARING INTERMEDIATE FOR SYNTHESIS OF SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST | LG CHEM, LTD. (KR) | 2024-01-04 | — | — | US | disclosed |
| CN-117242057-A | Process for preparing intermediates useful in the synthesis of sphingosine-1-phosphate receptor agonists | 株式会社LG化学 | 2023-12-15 | — | — | CN | disclosed |
| CN-117177964-A | Novel process for preparing sphingosine-1-phosphate receptor agonists | 株式会社LG化学 | 2023-12-05 | — | — | CN | disclosed |
| EP-4219443-A1 | METHOD FOR PREPARING INTERMEDIATE FOR SYNTHESIS OF SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST | Lg Chem, Ltd. (KR) | 2023-08-02 | — | — | EP | disclosed |
| WO-2022220610-A1 | METHOD FOR PREPARING INTERMEDIATE FOR SYNTHESIS OF SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST | 주식회사 엘지화학 | 2022-10-20 | — | — | WO | disclosed |
| WO-2022220611-A1 | NOVEL METHOD FOR PREPARING SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST | 주식회사 엘지화학 | 2022-10-20 | — | — | WO | disclosed |
| WO-2022080813-A1 | METHOD FOR PREPARING INTERMEDIATE FOR SYNTHESIS OF SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST | 주식회사 엘지화학 | 2022-04-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240002322-A1 | METHOD FOR PREPARING INTERMEDIATE FOR SYNTHESIS OF SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST | S1PR5, S1PR1, S1PR3 | MAPT 4186/4885MEN1 2350/4885KMT2A 4028/4885 |
| US-20240217935-A1 | METHOD FOR PREPARING INTERMEDIATE FOR SYNTHESIS OF SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST | S1PR4, S1PR1, S1PR3 | MAPT 4108/4885MEN1 1392/4885KMT2A 3293/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.